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INTRODUCTION
CD30-positive anaplastic large-cell lymphoma (ALCL) is
a rare subtype of non-Hodgkin’s lymphoma that was described
by Stein et al. in 1985 (1). The lymphoma usually occurs in
lymph nodes, but the disease is known to involve various extra-
nodal sites such as the skin (the most common site), and bone,
lung, spleen and the gastrointestinal tract (2). In Korea, Cho
et al. (3) have reported on multiorgan involvement of ALCL
that included the stomach.
Primary gastric CD30-positive ALCLs are very rare, and
there have been only a few such cases reported worldwide. Di-
stinguishing gastric ALCLs from other the carcinomas or sar-
comas may be confusing (2, 4, 5). Thus, a careful histologic
examination for such cases is needed. We report here on a case
of gastric Ki-1-positive ALCL that was proven pathologically.
To the best of our knowledge, this is the first reported case of
primary gastric ALCL in Korea.
CASE REPORT
In March 2004, a 50-yr-old woman was admitted to our
hospital complaining of epigastric pain and severe anterior
chest pain of 1 week duration. She was without any signifi-
cant prior medical history. An electrocardiogram and an echo-
cardiogram showed no significant abnormalities of the heart.
We concluded that the chest pain was atypical and that it did
not originate from the heart. Gastroendoscopic examination
revealed a geographic mucosal irregularity at the antrum (Fig.
1A), and we performed a biopsy at the site. The pathology
examination showed undifferentiated anaplastic neoplasm.
Endoscopic ultrasonography showed the mucosal thickening
(Fig. 1B), and the computerized tomography scan of the abdo-
men showed no evidence of distant metastasis. We performed
follow-up gastroendoscopic examination after 2 weeks. The
lesion was then more aggravated; her pain was persistent and
did not respond to H2-blocker or proton pump inhibitors.
She underwent total gastrectomy and the dissection of 16 re-
gional lymph nodes. 
The gross finding of the resected stomach tissue revealed an
8×4.5 cm well-demarcated ulceroinfiltrative lesion at the
pyloric antrum along the lesser curvature (Fig. 2), which infil-
trated into the submucosal layer. There were many enlarged
lymph nodes. The microscopic examination of the resected
stomach tissue revealed a diffuse and solid proliferation of large
atypical cells with pleomorphic nuclei. Some giant tumor cells
were confined in the mucosa-submucosa area, and they show-
ed multiple nuclear lobulations (Fig. 3A). 
An immunohistochemical study was performed on the for-
malin-fixed, paraffin-embedded surgical specimens by the
streptavidin-biotin-peroxidase complex method (LSAB kit;
DAKO, Japan). The tumor cells were positive for CD30 (Fig.
3B), vimentin and CD3, but they were negative for cytoker-
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A Case of Primary Gastric CD30-Positive Anaplastic Large-Cell 
Lymphoma
Gastric CD30-positive anaplastic large-cell lymphoma is a very rare disease. It is
sometimes difficult to distinguish it from undifferentiated carcinoma, sarcoma and
so on. We report here on a case of primary gastric anaplastic large-cell lymphoma.
A 50-yr-old woman complained of epigastric pain and severe chest pain for 1 week.
The gastroendoscopic examination revealed geographic mucosal irregularities with
shallow ulceration at the antrum. She underwent a total gastrectomy. The gross find-
ing of the resected stomach was an 8×4.5 cm sized ulceroinfiltrative lesion at the
pyloric antrum along the lesser curvature. The microscopic examination revealed
diffuse and solid proliferations of large atypical cells with pleomorphic nuclei. Immu-
nohistochemically, the tumor cells were positive for CD30, vimentin and CD3, and
this was a finding compatible with anaplastic large-cell lymphoma. To the best of our
knowledge, this is the first such reported case in Korea.
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atin, carcinoembryonic antigen (CEA), epithelial membrane
antigen (EMA), CD45, CD20, CD45RO and anaplastic lym-
phoma kinase (ALK) (Fig. 3C). Eight of the sixteen lymph
nodes contained metastasized tumor. 
The patient had no B symptoms, and there was no bone
marrow involvement. She had no palpable peripheral lymph
nodes and there were no abnormal findings on chest radio-
graphy. The initial laboratory test results were as follows:
white blood cell count, 4,300/ L; hemoglobin level, 10.3 g/dL;
platelet count, 196,000/ L; lactate dehydrogenase level, 716
IU/L (240-460 IU/L). The serum calcium level, aspartate ami-
notransferase level and alanine aminotransferase level were
normal. Her ECOG performance status was 1.
We diagnosed her as having CD30-positive primary gastric
ALCL IIE, and we started chemotherapy with cyclophospha-
mide, adriamycin, vincristine and prednisolone. After two
cycles of chemotherapy, prolonged leukopenia was noted. We
then performed a bone marrow examination. The bone mar-
row revealed a hypocellular marrow (the cellularity was 10%)
without evidence of tumor involvements. We decided to stop
any further chemotherapy and the patient was closely followed
up. At 7 months after diagnosis, the patient remains alive and
without tumor recurrence.
DISCUSSION
The stomach is a common site of extranodal lymphoma
occurrence, and most of the gastric lymphomas are of the B-
cell type. Primary gastric CD30-positive ALCLs are very rare.
There have been several previous reports regarding primary
gastric ALCL in Japan and China (6-9); however, to the best
of our knowledge, this is the first such reported case in Korea.
We can only guess that it is indeed a very rare disease.
The ALCL cells are large and they have pleomorphic or mul-
tiple nuclei. Thus, primary gastric ALCL is sometimes mis-
diagnosed as undifferentiated carcinoma, melanoma, histio-
cytic neoplasm, sarcoma and so on (2, 4, 5). Unfortunately, we
could not initially confirm the type of malignancy. The tumor
Fig. 2. A macroscopic picture of the total gastrectomy specimen.
The ulceroinfiltrative mass measuring 8×4.5 cm can be seen on
the lesser curvature of the antrum.
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Fig. 1. Gastroendoscopy shows a geographic mucosal irregularity at the antrum (A). Endoscopic ultrasonography shows submucosal thick-
ening of the stomach (arrows) (B).
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cells of ALCL are CD30 positive and usually express EMA
and one or more T-cell-associated antigens (1, 10). CD30 is
a transmembrane cytokine receptor of the tumor necrosis fac-
tor receptor family. In the pathologic condition, it is expressed
on the Reed-Sternberg cells of Hodgkin lymphoma and ALCL.
CD30 is also observed in many categories of lymphoid tumors
other than ALCL, and also can be expressed on embryonal
carcinoma, however, the positivity of CD30 is usually weak
in these cases. Other non-lymphoid malignant cells lack this
CD30 expression. Although expression of CD30 is the hall-
mark of ALCL, it is not specific just for this disease. There-
fore, it is necessary to perform other immunohistochemistry
tests for other lymphoid and non-lymphoid markers (11). In
our case, the tumor cells showed a similar morphology to those
of ALCL. Immunohistochemically, most of the tumor cells
were positive for CD30 and CD3, but negative for cytokera-
tin, CEA, EMA, thus confirming ALCL. 
Anaplastic lymphoma kinase (ALK) expression is found in
50-70% of CD30-positive ALCL, and 75% of these cases have
chromosomal abnormalities. ALCL is divided into three sub-
groups according to the ALK expression: ALK-positive sys-
temic ALCL, ALK-negative systemic ALCL, and primary cu-
taneous ALCL (ALK negative). ALK-positive ALCL usually
occurs at a younger age (15-30 yr), it is a male predominant
disease, it exhibits frequent B-symptoms, it is known to be
more chemosensitive and to have a better prognosis for survi-
val (14, 15). However, Sachiko et al. have reported that one of
three patients with gastric CD30-positive ALCL was positive
for ALK and EMA (6). In our case, the tumor cells were nega-
tive for ALK immunohistochemistry, and the clinical charac-
Fig. 3. Histologic and immunohistochemical pictures of the gastric
tumor. A high power view (H&E, ×400) shows a diffuse and solid
proliferation of large atypical cells with pleomorphic nuclei. Multi-
ple nuclear lobulations are noted (A). Positive immunoreactivity
with anti-CD30 (×400) and (B), negative immunoreactivity for ALK
(×400) (C).
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teristics of our case were in accord with the usual clinical find-
ings for ALK-negative systemic ALCL. 
Gastric T/null-cell lymphoma may be associated with Heli-
cobacter pylori infection. Bariol et al. have reported gastric T-cell
lymphoma regression with the eradication of H. pylori (9). In
the present case, although we could not find H. pylori in the
biopsy specimen, the urea breath test was positive. We per-
formed H. pylori eradication with amoxicillin, clarythromycin
and rabeprazole before obtaining the pathology results. How-
ever, the lesion became aggravated. Further study on the asso-
ciation between gastric T-cell lymphoma and H. pylori infec-
tion is needed.
Little is known about the treatment and prognosis of gas-
tric ALCL. Most cases of gastric ALCL have been treated with
surgical resection, and some patients have received chemothe-
rapy after surgery. A few patients have received chemothera-
py alone (12). The outcomes of treatment have been variable
despite the different methods of treatment. Cases of primary
gastric ALCL are very rare, so a standard treatment is not kno-
wn. T-cell ALCL is generally an aggressive lymphoma, and
Nakamura et al. have reported on rapidly progressive gastric
ALCL (8). The treatment regimens for primary systemic
ALCL are the same as those used for diffuse large B-cell lym-
phoma (13). Therefore, we performed chemotherapy with
CHOP (cyclophosphamide, doxorubicin hydrochloride, on-
covin [vincristine], and prednisolone) after the patient’s total
gastrectomy. After two cycles of chemotherapy, we were forced
to stop the treatment because of the poor bone marrow reser-
voir. At 5 months after diagnosis, the patient is alive and there
has been no tumor recurrence.
We can suggest that ALCL should be considered among the
cases of pleomorphic tumors of the stomach. 
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